Here are six points:
1. The company is also initiating a full U.S. commercial launch of the implant.
2. The iFuse-3D Implant is the first 3-D-printed titanium implant for SI joint use.
3. The company leveraged proprietary 3-D-printing technology to create a patented fenestrated design and porous surface to mirror cancellous bone’s trabecular structure.
4. The implant promotes bone ongrowth, ingrowth and through growth, demonstrated in a study published in the International Journal of Spine Surgery.
5. More than 50 peer-reviewed publications support the iFuse Implant’s triangular titanium design. The iFuse Implant system offers a minimally invasive solution to fuse the SI joint.
6. The iFuse-3D features 250 percent greater surface area than the iFuse Implant.
More articles on MIS:
MIS spine market to grow at 14.7% CAGR through 2022: 10 market observations
Blue Cross and Blue Shield of Vermont adds minimally invasive SI joint fusion coverage for 200k members: 4 key notes
Minimally invasive vs. open decompression for lumbar spinal stenosis: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.